Latest News about FATE
Recent news which mentions FATE
From Benzinga
 From MarketWatch
 From Benzinga
 
   These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
   
  
  
  May 02, 2022
  From MarketWatch
 
   What 4 Analyst Ratings Have To Say About Fate Therapeutics
   
  March 04, 2022
  Tickers 
   FATE
  
  
  From Benzinga
 
   Earnings Scheduled For February 28, 2022
   
  
  
  February 28, 2022
  From Benzinga
 
   The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
   
  
  
  February 27, 2022
  From Benzinga
 
   2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
   
  
  
  February 08, 2022
  From Benzinga
 From Benzinga
 
   Here's How Much $100 Invested In Fate Therapeutics 5 Years Ago Would Be Worth Today
   
  January 05, 2022
  Tickers 
   FATE
  
  
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
   
  
  
  December 15, 2021
  From Benzinga
 
   10 Biggest Price Target Changes For Wednesday
   
  
  
  December 15, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
   
  
  
  December 14, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
   
  
  
  December 07, 2021
  From Benzinga
 
   Cathie Wood Likes Fate Therapeutics, Should You?
   
  
  
  December 01, 2021
  From Motley Fool
 
   3 Biotech Stocks That Can Double Your Money, According to Wall Street
   
  
  
  November 25, 2021
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021
   
  
  
  November 09, 2021
  From Benzinga
 
   Fate Therapeutics, inc (FATE) Q3 2021 Earnings Call Transcript
   
  November 05, 2021
  Tickers 
   FATE
  
  
  From Motley Fool
 
   The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
   
  
  
  November 04, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
   
  
  
  October 31, 2021
  From Benzinga
 
   3 Biotech Stocks to Watch Now
   
  
  
  October 12, 2021
  From Benzinga
 
   Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain
   
  
  
  September 14, 2021
  From Motley Fool
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021
   
  
  
  August 26, 2021
  From Benzinga
 
   58 Biggest Movers From Friday
   
  
  
  August 23, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
